兽医外科市场：按动物类型、手术类型、技术和最终用户划分，全球预测，2026-2032年

预计到 2025 年，兽医外科市场价值将达到 445.5 亿美元，到 2026 年将成长至 477.8 亿美元，到 2032 年将达到 731.4 亿美元，复合年增长率为 7.33%。

主要市场统计数据
基准年 2025	445.5亿美元
预计年份：2026年	477.8亿美元
预测年份 2032	731.4亿美元
复合年增长率 (%)	7.33%

权威概述了现代兽医外科生态系统，其发展受到日益复杂的临床情况、技术进步和多样化的医疗保健服务环境的驱动。

兽医外科领域已发展成为一个融合了先进临床技术、科技创新和不断演进的医疗服务模式的复杂领域。本文概述了塑造现代兽医实践的核心要素：病例类型日益多样化，涵盖伴侣动物、马匹和家禽/牲畜；手术类型日益复杂，涉及牙科、神经科、眼科、整形外科和软组织介入；以及微创手术、开放式手术和机器人辅助手术等多种技术的逐步应用。这些趋势共同作用，正在改变临床医生、医疗机构和供应方相关人员对投资和营运流程的优先排序。

重大变革正在重新定义兽医外科实践，影响临床工作流程、筹资策略和组织能力。

近年来，兽医外科领域经历了变革性的变化，重塑了临床工作流程、资金配置和竞争格局。影像学和手术全期监测技术的进步提高了诊断准确性，并扩大了可进行的复杂手术范围。同时，微创和关节镜技术的广泛应用缩短了恢復时间，改变了饲主对术后效果的预期。此外，机器人技术和先进电外科平台的整合应用，使得手术操作更具可重复性，尤其是在整形外科和软组织外科领域，这也促使训练需求和筹资策略改变。

评估美国2025年关税变化将如何重塑供应链、采购决策以及获得先进外科技术的途径。

2025年的政策环境将出现关税变化，将对外科器械和耗材的采购、库存管理和策略采购产生影响。进口外科器械、机器人组件和特种植入的关税调整可能导致依赖全球供应商的医疗专业人员和机构的前置作业时间延长和到岸成本增加。这些变化迫使各机构重新评估供应商合约、保固条款和长期维护协议，从而显着影响资本支出週期和复杂手术中的服务可用性。

我们透过可操作的細項分析来支持临床和商业性策略的製定，该分析将动物物种、治疗类别、外科手术程序和最终用户概况联繫起来。

市场区隔揭示了不同的需求驱动因素和营运要求，这些因素应指南产品开发和市场进入策略。不同动物物种的市场动态存在差异：伴侣动物、马匹和家畜/家禽。伴侣动物类别进一步细分为猫和狗，而家畜/家禽类别则区分为牲畜和家禽。每个动物群体都有其独特的解剖结构、麻醉通讯协定以及植入和器械偏好，都会影响设备设计和临床医生培训的重点。

区域比较分析突显了医疗保健结构、法规环境和需求讯号的差异如何影响外科治疗方法。

区域差异影响着服务提供、监管和合作伙伴选择的策略重点。美洲地区拥有成熟的、功能完善的转诊网络和完善的兽医医院体系，推动了对先进诊断影像、整形外科和微创手术工具的需求，同时也促进了合作临床研究和专科培训计画的发展。相较之下，欧洲、中东和非洲地区则呈现显着的差异。一些欧洲市场强调标准化的临床通讯协定和更严格的监管，中东地区则有选择地投资于三级转诊能力，而非洲部分地区则致力于扩大外科手术的覆盖范围和发展人力资源。

深入洞察产业竞争格局，了解设备、服务和培训的整合解决方案如何提升临床疗效和营运韧性。

整个价值链上的关键参与者正朝着整合设备、服务、培训和数位化支援的一体化解决方案方向发展。手术器械製造商越来越多地将围手术全期培训计画和远端维护合约打包销售，以减轻临床医生的工作量。同样，开发成像、遥测和机器人系统的技术提供者也优先考虑互通性和以用户为中心的设计，以缩短混合诊疗环境下的学习曲线。医疗设备开发商与兽医学院附属医院之间的策略合作日益普遍，这有助于加速临床检验，并促进以案例为基础的新技术培训。

为领导者提供切实可行的优先建议，以加强供应链韧性、加速临床部署并建立满足供应商需求的商业模式。

产业领导者应优先采取策略行动，平衡短期韧性和长期能力建构。首先，实现供应商网路多元化，并协商灵活的服务合同，以减轻关税引发的成本转移和供应中断对营运的影响。其次，投资于结合模拟学习和指导的临床医生培训项目，以加速微创和机器人技术的安全应用，减少手术操作差异和併发症。第三，设计符合每位终端用户需求的客製化产品和服务组合，以降低应用门槛，确保转诊机构、诊所和医院能够获得适当的资金筹措和共享使用协议。

为了检验临床和操作方面的见解，我们采用了一种稳健的混合研究途径，结合了从业人员访谈、通讯协定分析和三角验证。

本分析所依据的研究严格验证并整合了第一手和第二手证据，以确保其可靠性和相关性。第一手资料包括对执业外科医生、医院管理人员、供应链经理以及转诊中心、兽医医院和诊所的高级临床医生进行的详细访谈，并辅以结构化检验，以了解营运重点和推广障碍。第二手研究整合了同行评审的临床文献、监管指南、医疗设备註册资料和技术规范，以整理技术发展路径和安全考量。

这份简明扼要、全面且全面的分析报告，重点阐述了临床创新、营运策略和区域差异的交汇点，提出了决定未来兽医外科领域领导地位的关键因素。

总之，兽医外科领域正处于技术能力、临床专长和商业策略交会的十字路口，共同塑造未来的医疗保健标准。微创技术、先进影像技术和新兴机器人应用的融合，正在拓展可治疗疾病的范围；而按动物种类、手术类型、技术类型和最终用户进行细分，则为有针对性的创新和应用提供了清晰的路径。考虑到基础设施、监管和投资意愿的区域差异，需要製定既能反映当地实际情况又不放弃全球最佳实践的细緻策略。

目录

第一章：序言

第二章：调查方法

• 调查设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查的前提
• 研究限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会映射
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：兽用外科市场：依动物类型划分

• 伴侣动物
  • 猫
  • 狗
• 马匹
• 畜禽
  • 家畜
  • 家禽

第九章：兽医外科市场：依手术类型划分

• 牙科
• 神经外科
• 眼科
• 整形外科
• 软组织

第十章：兽用外科市场：依技术划分

• 微创手术
  • 关节镜手术
  • 腹腔镜
• 开放性手术
• 机器人

第十一章 兽医外科手术市场：依最终使用者划分

• 转诊中心
• 动物诊所
• 动物医院

第十二章 兽医外科手术市场：依地区划分

• 北美洲和南美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 兽医外科手术市场：依组别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 兽医外科手术市场：依国家划分

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章：美国：兽医外科市场

第十六章 中国：兽用外科器械市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Covetrus, Inc.
• Henry Schein, Inc.
• Heska Corporation
• Jorgen Kruuse A/S
• Medtronic plc
• Midmark Corp.
• Patterson Companies, Inc.
• Smith & Nephew plc
• Stryker Corporation
• Vetoquinol SA
• Zimmer Biomet Holdings, Inc.

The Veterinary Surgical Procedures Market was valued at USD 44.55 billion in 2025 and is projected to grow to USD 47.78 billion in 2026, with a CAGR of 7.33%, reaching USD 73.14 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 44.55 billion
Estimated Year [2026]	USD 47.78 billion
Forecast Year [2032]	USD 73.14 billion
CAGR (%)	7.33%

An authoritative orientation to the modern veterinary surgical ecosystem driven by clinical complexity, technology adoption and diverse care delivery settings

The landscape of veterinary surgical procedures has matured into a complex intersection of clinical sophistication, technological innovation, and evolving care delivery models. This introduction frames the core elements shaping contemporary practice: the diversification of case mix across companion animals, equine patients and livestock poultry; the rising complexity of procedure types spanning dental, neurological, ophthalmic, orthopedic and soft tissue interventions; and the progressive adoption of varied techniques such as minimally invasive approaches, open surgery and robotic assistance. Together these dynamics are reshaping how clinicians, institutions and supply-side stakeholders prioritize investments and operational processes.

As we move from descriptive observation to strategic perspective, it is essential to acknowledge the heterogeneous end-user landscape that includes referral centers, traditional veterinary clinics and hospital settings. Each of these settings imposes different expectations for equipment, staffing, perioperative protocols and outcome metrics. Moreover, shifting owner expectations for companion animals, regulatory attention to food-animal welfare, and expanding specialty training for veterinarians are reinforcing a trajectory toward higher-acuity, technology-enabled care. This introduction establishes the baseline for the deeper analyses that follow, spotlighting practical levers that influence adoption, reimbursement-like mechanisms in different jurisdictions, and the operational choices that translate clinical capability into sustainable service lines.

Key transformative shifts redefining veterinary surgical practice that impact clinical workflows, procurement strategies and institutional capabilities

Over recent years the veterinary surgical field has experienced transformative shifts that recalibrate clinical workflows, capital allocation and competitive positioning. Advances in imaging and perioperative monitoring have raised diagnostic precision and broadened candidacy for complex procedures, while the proliferation of minimally invasive and arthroscopic techniques has shortened recovery times and shifted owner expectations for postoperative outcomes. Concurrently, integration of robotics and enhanced electrosurgical platforms is enabling more reproducible interventions, especially in orthopedic and soft tissue specialties, which alters training requirements and procurement strategies.

In parallel, changes in practice organization are notable: referral centers are consolidating high-acuity caseloads while general clinics increasingly partner with specialty providers or develop hybrid service models. This redistribution of case loads amplifies demand for specialized consumables and device interoperability. Supply chain resilience has become a strategic priority, prompting stakeholders to seek diversified sourcing and local service agreements. Finally, regulatory and welfare imperatives are driving greater standardization of surgical protocols and outcome reporting. Collectively, these shifts are not isolated; they create cascading effects across staffing, capital planning and vendor relationships, and require cross-functional orchestration to translate clinical innovation into measurable improvements in care quality and operational efficiency.

Assessment of how tariff shifts in the United States are reshaping supply chains, procurement decisions and access to advanced surgical technologies in 2025

The policy environment in 2025 has introduced tariff dynamics that reverberate across procurement, inventory management and strategic sourcing for surgical equipment and consumables. Tariff adjustments on imported surgical instruments, robotics components and specialized implants can extend lead times and increase landed costs for practitioners and institutions that depend on global suppliers. These changes compel organizations to reassess supplier contracts, warranty provisions, and long-term maintenance agreements, with material effects on capital expenditure cycles and service availability for high-complexity procedures.

Beyond immediate cost implications, tariffs influence supplier behavior: manufacturers may accelerate localization of manufacturing, restructure distribution networks, or shift product portfolios toward higher-margin items. For end users such as referral centers, veterinary clinics and hospitals, there is a parallel need to evaluate inventory buffers and to negotiate service-level agreements that account for cross-border logistics risk. In addition, research and innovation pathways can be affected if components for next-generation devices face import constraints, slowing clinical validation or commercialization timelines. Ultimately, the cumulative impact of tariff policy requires coordinated responses from procurement, clinical leadership and industry partners to preserve continuity of care and maintain access to advanced surgical modalities.

Actionable segmentation insights linking animal types, procedure categories, surgical techniques and end-user profiles to inform targeted clinical and commercial strategies

Segmentation reveals differentiated demand drivers and operational requirements that should guide product development and go-to-market strategies. Based on Animal Type, market dynamics diverge across Companion Animal, Equine Animal, and Livestock Poultry; the Companion Animal category further differentiates into Cats and Dogs, and the Livestock Poultry category distinguishes between Livestock and Poultry. Each animal grouping presents unique anatomical considerations, anesthesia protocols and implant or instrument preferences that influence device design and clinician training priorities.

Based on Procedure Type, the spectrum from dental through neurological, ophthalmic, orthopedic and soft tissue interventions maps to distinct capital intensity and consumable profiles, creating varied adoption pathways. Based on Technique, the field encompasses Minimally Invasive, Open, and Robotic approaches, with Minimally Invasive further studied across Arthroscopic and Laparoscopic modalities; this technical segmentation highlights a trajectory toward less invasive care that demands investment in specialized optics, insufflation and instrumentation. Finally, based on End User, differentiation among Referral Centers, Veterinary Clinics, and Veterinary Hospitals underscores differences in case complexity, procurement sophistication and staff specialization. Synthesizing these segment layers enables targeted clinical education, tailored product bundles and differentiated service models that align with the clinical and commercial needs of each segment.

Comparative regional analysis highlighting how divergent healthcare structures, regulatory environments and demand signals shape surgical capability adoption

Regional variation shapes strategic priorities across service delivery, regulation and partner selection. The Americas tend to exhibit a mature mix of high-specification referral networks and well-established veterinary hospital systems that drive demand for advanced imaging, orthopedic and minimally invasive toolsets, while also fostering collaborative clinical research and specialty training programs. In contrast, Europe, Middle East & Africa displays pronounced heterogeneity: several European markets emphasize standardized clinical protocols and higher regulatory scrutiny, the Middle East is investing selectively in tertiary referral capacity, and parts of Africa are focusing on expanding baseline surgical access and workforce development.

Meanwhile, the Asia-Pacific region presents a dual profile of rapidly expanding companion animal care in urban centers and a continuing need for scalable solutions in emerging markets. Across all regions, localization of supply chains, region-specific training initiatives, and tailored financing solutions play critical roles in adoption. Transitioning between regional profiles requires adaptive commercialization tactics that respect regulatory nuance, local epidemiology, and varying owner expectations, while leveraging partnerships with academic institutions and regional distributors to accelerate capability building and technology diffusion.

Industry-level intelligence on competitive convergence toward integrated device, service and training solutions that enhance clinical outcomes and operational resilience

Key players across the value chain are converging toward integrated offerings that pair devices with service, training and digital support. Manufacturers of surgical instrumentation are increasingly bundling perioperative training programs and remote maintenance agreements to reduce operational friction for clinicians. Similarly, technology providers that develop imaging, telemetry and robotic systems are prioritizing interoperability and user-centric design to lower the learning curve in mixed-practice environments. Strategic partnerships between device innovators and veterinary teaching hospitals are becoming common, accelerating clinical validation and facilitating case-based training for new techniques.

On the provider side, referral centers are consolidating specialty expertise and investing in multidisciplinary teams that can manage complex neurological, orthopedic and ophthalmic cases. Veterinary hospitals and clinics that aim to expand service scope are forming co-investment arrangements or equipment-sharing consortia to access capital-intensive modalities. Across these movements, the competitive frontier is defined by the ability to deliver demonstrable clinical outcomes, scalable training pathways, and robust post-sale support rather than by single-product superiority. This evolving ecosystem rewards entities that can align clinical efficacy with pragmatic operational support and continuous education.

Practical and prioritized recommendations for leaders to strengthen supply resilience, accelerate clinical adoption and align commercial models with provider needs

Industry leaders should prioritize strategic actions that balance near-term resilience with long-term capability building. First, diversify supplier networks and negotiate flexible service contracts to mitigate the operational impacts of tariff-driven cost shifts and supply disruptions. Second, invest in clinician training programs that accelerate safe adoption of minimally invasive and robotic techniques, pairing simulation-based learning with proctoring to reduce procedural variability and complications. Third, design product and service bundles that align with the needs of distinct end users, ensuring that referral centers, clinics and hospitals can access appropriate financing or shared-use arrangements to lower adoption barriers.

Additionally, pursue data-driven outcomes measurement to demonstrate value for owners and regulators, and leverage these metrics in commercial discussions and payer dialogs. Expand partnerships with academic centers and regional training hubs to build the talent pipeline and validate new device applications. Finally, adopt modular product strategies that allow incremental upgrades rather than wholesale replacement, thereby preserving capital flexibility for providers and creating predictable upgrade revenue streams for suppliers. These combined measures will enhance clinical capacity, protect margin, and position organizations to capture growth as procedural complexity continues to rise.

A robust mixed-methods research approach combining practitioner interviews, protocol analysis and triangulation to validate clinical and operational findings

The research underpinning this analysis integrates primary and secondary evidence streams with rigorous validation to ensure credibility and relevance. Primary inputs included in-depth interviews with practicing surgeons, hospital administrators, supply chain leaders, and senior clinicians across referral centers, veterinary hospitals and clinics, augmented by structured surveys to capture operational priorities and adoption barriers. Secondary research synthesized peer-reviewed clinical literature, regulatory guidance, device registries and technical specifications to map technological trajectories and safety considerations.

Data were triangulated through comparative analysis across animal types, procedure categories and techniques, and regional patterns were cross-validated with institutional case mix data and procurement records where available. Qualitative insights were coded to identify recurring themes in training, interoperability and post-market support. Throughout the methodology, care was taken to anonymize respondent data, to document source provenance, and to subject findings to internal expert review, ensuring that the conclusions reflect both practical experience and empirical evidence rather than anecdote alone.

Concise synthesis emphasizing the intersection of clinical innovation, operational strategy and regional nuance as determinants of future leadership in veterinary surgery

In conclusion, the veterinary surgical domain is at an inflection point where technological capability, clinical specialization and commercial strategy intersect to shape future standards of care. The confluence of minimally invasive techniques, enhanced imaging, and nascent robotic applications is expanding the envelope of treatable conditions, while segmentation by animal type, procedure, technique and end-user exposes clear pathways for targeted innovation and adoption. Regional differences in infrastructure, regulation and investment appetite require nuanced strategies that reflect local realities without forgoing global best practices.

Leaders who integrate supply chain resilience, clinician education and data-driven outcome measurement into their strategic plans will be best positioned to translate capability into consistent, high-value care. The recommendations and insights presented here provide a foundation for operationalizing those priorities and for making informed choices about product development, partnership models and market entry approaches. As clinical expectations rise, the ability to align clinical effectiveness with sustainable business models will determine which organizations lead the next wave of specialty veterinary care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Surgical Procedures Market, by Animal Type

• 8.1. Companion Animal
  • 8.1.1. Cats
  • 8.1.2. Dogs
• 8.2. Equine Animal
• 8.3. Livestock Poultry
  • 8.3.1. Livestock
  • 8.3.2. Poultry

9. Veterinary Surgical Procedures Market, by Procedure Type

• 9.1. Dental
• 9.2. Neurological
• 9.3. Ophthalmic
• 9.4. Orthopedic
• 9.5. Soft Tissue

10. Veterinary Surgical Procedures Market, by Technique

• 10.1. Minimally Invasive
  • 10.1.1. Arthroscopic
  • 10.1.2. Laparoscopic
• 10.2. Open
• 10.3. Robotic

11. Veterinary Surgical Procedures Market, by End User

• 11.1. Referral Centers
• 11.2. Veterinary Clinics
• 11.3. Veterinary Hospitals

12. Veterinary Surgical Procedures Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Veterinary Surgical Procedures Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Veterinary Surgical Procedures Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Veterinary Surgical Procedures Market

16. China Veterinary Surgical Procedures Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. B. Braun Melsungen AG
• 17.6. Becton, Dickinson and Company
• 17.7. Covetrus, Inc.
• 17.8. Henry Schein, Inc.
• 17.9. Heska Corporation
• 17.10. Jorgen Kruuse A/S
• 17.11. Medtronic plc
• 17.12. Midmark Corp.
• 17.13. Patterson Companies, Inc.
• 17.14. Smith & Nephew plc
• 17.15. Stryker Corporation
• 17.16. Vetoquinol S.A.
• 17.17. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY EQUINE ANIMAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY EQUINE ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY EQUINE ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY NEUROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY NEUROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SOFT TISSUE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SOFT TISSUE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SOFT TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ARTHROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ARTHROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ARTHROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REFERRAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REFERRAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REFERRAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 70. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 71. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 72. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 73. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 74. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 75. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 76. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 77. AMERICAS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 78. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 80. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 81. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 82. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 83. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 84. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 85. NORTH AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 86. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 87. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 88. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 89. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 90. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 91. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 92. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 93. LATIN AMERICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 94. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 95. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 96. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 102. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 103. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 104. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 105. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 106. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 107. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 108. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 109. EUROPE VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 110. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 111. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 112. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 113. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 114. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 115. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 116. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 117. MIDDLE EAST VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 119. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 120. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 121. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 122. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 123. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 124. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 125. AFRICA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 126. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 127. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 128. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 129. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 130. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 131. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 132. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 133. ASIA-PACIFIC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 134. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 135. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 136. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 137. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 138. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 139. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 140. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 141. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 142. ASEAN VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 143. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 144. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 145. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 146. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 147. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 148. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 149. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 150. GCC VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 151. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 152. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 153. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 154. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 155. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 156. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 157. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 158. EUROPEAN UNION VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 159. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 160. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 161. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 162. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 163. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 164. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 165. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 166. BRICS VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 167. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 168. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 169. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 170. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 171. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 172. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 173. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 174. G7 VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 175. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 176. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 177. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 178. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 179. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 180. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 181. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 182. NATO VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 183. GLOBAL VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 184. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 185. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 186. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 187. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 188. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 189. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 190. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 191. UNITED STATES VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 192. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 193. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
• TABLE 194. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
• TABLE 195. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY LIVESTOCK POULTRY, 2018-2032 (USD MILLION)
• TABLE 196. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
• TABLE 197. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
• TABLE 198. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
• TABLE 199. CHINA VETERINARY SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)